Mitsubishi UFJ Securities’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Mitsubishi UFJ Securities's BIIB Position: Q1 2020 in Review
Mitsubishi UFJ Securities sold out of Biogen (BIIB) in Q1 2020, closing a stake of 690 shares — an estimated $205K sold.
Mitsubishi UFJ Securities first reported a position in BIIB in Q1 2015 and held it in 17 quarters. The position peaked at $293K in Q3 2018. 1,099 funds tracked by Wall St. Rank hold BIIB as of Q1 2020.
- Mitsubishi UFJ Securities reported no remaining Biogen position as of Q1 2020 after selling out during the quarter.
- Mitsubishi UFJ Securities sold 690 Biogen shares in Q1 2020, an estimated $205K.
- Mitsubishi UFJ Securities first reported a position in Biogen in Q1 2015 and held it in 17 quarters.
- Mitsubishi UFJ Securities's Biogen position peaked at $293K in Q3 2018.
- 1,099 funds tracked by Wall St. Rank held Biogen as of Q1 2020.
Based on Mitsubishi UFJ Securities's 13F filing for Q1 2020, filed 13 May 2020.